Last updated on November 2017
Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin
Brief description of study
Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin
Detailed Study Description
Type 2 Diabetes? Currently using Insulin? Such as Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin
You may be eligible to participate in a 58 week Research Study if you are:
- Diagnosed with Type 2 Diabetes
- Currently using insulin
- Age 18 or older
ClinicalTrials.gov Identifier: NCT03078478
Clinical Study Identifier: TX9843